Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Piotr Eder

Showing results (101-110 of 114) with videos related to

Pageof 12
Sort By:
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 28, 2025
Relapse rate following withdrawal of vedolizumab and ustekinumab in patients with inflammatory bowel disease - a multicenter retrospective controlled study. The VEDUST-EXIT StudyAhmad Albshesh, Piotr Kucha, Daniela Pugliese, et al.
Therapeutic Advances in Gastroenterology|February 23, 2023
Real-world outcomes of 54-week vedolizumab therapy and response durability after treatment discontinuation in ulcerative colitis: results from a multicenter prospective POLONEZ studyPiotr Eder, Maria Kłopocka, Halina Cichoż-Lach, et al.
Therapeutic Advances in Gastroenterology|September 6, 2021
Characteristics of patients with moderate-to-severe ulcerative colitis treated with vedolizumab: results from a Polish multicenter, prospective, observational real-life study (the POLONEZ study)Halina Cichoż-Lach, Agata Michalak, Maria Kopertowska-Majchrzak, et al.
The American Journal of Gastroenterology|February 2, 2024
Rates of Adverse Events in Patients With Ulcerative Colitis Undergoing Colectomy During Treatment With Tofacitinib vs Biologics: A Multicenter Observational StudyGabriele Dragoni, Tommaso Innocenti, Aurelién Amiot, et al.
Journal of Clinical Medicine|March 17, 2025
Efficacy of Upadacitinib Induction Treatment in Moderate-to-Severe Ulcerative Colitis Including Intestinal Ultrasound Assessment: A Multicenter, Real-World Observational StudyMagdalena Kaniewska, Konrad Lewandowski, Michał Krogulecki, et al.
Canadian Journal of Gastroenterology & Hepatology|June 2, 2026
Clinical Response and Improvement of the Quality of Life, Fatigue, Mood, and Sleep Disturbances During Vedolizumab Induction Therapy in Polish Patients With Moderate-to-Severe Ulcerative Colitis or Crohn's DiseaseAgata Michalak, Iwona Zawada, Anna Deskur, et al.
Journal of Crohn'S & Colitis|October 12, 2021
ECCO Guidelines on Therapeutics in Ulcerative Colitis: Surgical TreatmentAntonino Spinelli, Stefanos Bonovas, Johan Burisch, et al.
Journal of Crohn'S & Colitis|June 7, 2023
Autoimmune Pancreatitis in Patients with Inflammatory Bowel Disease: A Real-World Multicentre Collaborative ECCO CONFER StudyPiotr Eder, Bram Verstock, Emma Culver, et al.
Journal of Crohn'S & Colitis|January 20, 2024
Prophylactic Versus Endoscopy-driven Treatment of Crohn's Postoperative Recurrence: A Retrospective, Multicentric, European Study [PORCSE Study]Jeroen Geldof, Marie Truyens, Michiel Hanssens, et al.
Medicina (Kaunas, Lithuania)|September 27, 2025
Acute Pancreatitis in Inflammatory Bowel Disease: Results from the European Pandora StudyMaria Cristina Conti Bellocchi, Martina Cattani Mottes, Andreas Blesl, et al.
Pageof 12

Showing results (101-110 of 114) with videos related to

Sort By:
Pageof 12
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 28, 2025
Relapse rate following withdrawal of vedolizumab and ustekinumab in patients with inflammatory bowel disease - a multicenter retrospective controlled study. The VEDUST-EXIT StudyAhmad Albshesh, Piotr Kucha, Daniela Pugliese, et al.
Therapeutic Advances in Gastroenterology|February 23, 2023
Real-world outcomes of 54-week vedolizumab therapy and response durability after treatment discontinuation in ulcerative colitis: results from a multicenter prospective POLONEZ studyPiotr Eder, Maria Kłopocka, Halina Cichoż-Lach, et al.
Therapeutic Advances in Gastroenterology|September 6, 2021
Characteristics of patients with moderate-to-severe ulcerative colitis treated with vedolizumab: results from a Polish multicenter, prospective, observational real-life study (the POLONEZ study)Halina Cichoż-Lach, Agata Michalak, Maria Kopertowska-Majchrzak, et al.
The American Journal of Gastroenterology|February 2, 2024
Rates of Adverse Events in Patients With Ulcerative Colitis Undergoing Colectomy During Treatment With Tofacitinib vs Biologics: A Multicenter Observational StudyGabriele Dragoni, Tommaso Innocenti, Aurelién Amiot, et al.
Journal of Clinical Medicine|March 17, 2025
Efficacy of Upadacitinib Induction Treatment in Moderate-to-Severe Ulcerative Colitis Including Intestinal Ultrasound Assessment: A Multicenter, Real-World Observational StudyMagdalena Kaniewska, Konrad Lewandowski, Michał Krogulecki, et al.
Canadian Journal of Gastroenterology & Hepatology|June 2, 2026
Clinical Response and Improvement of the Quality of Life, Fatigue, Mood, and Sleep Disturbances During Vedolizumab Induction Therapy in Polish Patients With Moderate-to-Severe Ulcerative Colitis or Crohn's DiseaseAgata Michalak, Iwona Zawada, Anna Deskur, et al.
Journal of Crohn'S & Colitis|October 12, 2021
ECCO Guidelines on Therapeutics in Ulcerative Colitis: Surgical TreatmentAntonino Spinelli, Stefanos Bonovas, Johan Burisch, et al.
Journal of Crohn'S & Colitis|June 7, 2023
Autoimmune Pancreatitis in Patients with Inflammatory Bowel Disease: A Real-World Multicentre Collaborative ECCO CONFER StudyPiotr Eder, Bram Verstock, Emma Culver, et al.
Journal of Crohn'S & Colitis|January 20, 2024
Prophylactic Versus Endoscopy-driven Treatment of Crohn's Postoperative Recurrence: A Retrospective, Multicentric, European Study [PORCSE Study]Jeroen Geldof, Marie Truyens, Michiel Hanssens, et al.
Medicina (Kaunas, Lithuania)|September 27, 2025
Acute Pancreatitis in Inflammatory Bowel Disease: Results from the European Pandora StudyMaria Cristina Conti Bellocchi, Martina Cattani Mottes, Andreas Blesl, et al.
Pageof 12